Subutex treatment (buprenorphine monoproduct).
Subutex is buprenorphine without naloxone — clinically equivalent to Suboxone for the buprenorphine effect, and specifically indicated during pregnancy or when naloxone is contraindicated.
Kentucky Medicaid plans typically cover Subutex.
Kentucky Medicaid plans typically cover buprenorphine monoproduct (Subutex / generic buprenorphine), with most plans requiring documentation of the clinical indication. Pregnancy-related authorizations are typically expedited.
When Subutex is the right choice.
Pregnancy
Subutex is the preferred buprenorphine formulation during pregnancy. Naloxone (the second ingredient in Suboxone) is contraindicated in pregnancy because of potential fetal harm, so prescribers move pregnant patients to Subutex while maintaining the same induction and maintenance approach.
Naloxone sensitivity
A small subset of patients have documented sensitivity or adverse reaction to naloxone. For these patients, Subutex provides the same therapeutic buprenorphine without the second-line ingredient that triggered the reaction.
Clinical judgment
In some clinical contexts a prescriber may choose Subutex over Suboxone — for example, when initiating medication-assisted treatment (MAT) in a controlled setting where misuse risk is already addressed by clinical observation.
Common questions about Subutex.
What's the difference between Subutex and Suboxone?
Subutex is buprenorphine alone. Suboxone is buprenorphine plus naloxone — an opioid antagonist added to deter misuse via injection. For oral/sublingual use as intended, the two are clinically equivalent. Suboxone is the more common prescription because the naloxone serves as a misuse-deterrent layer.
Why is Subutex preferred during pregnancy?
Naloxone in Suboxone is contraindicated in pregnancy because of potential fetal harm. Subutex removes the naloxone while keeping the therapeutic buprenorphine, making it the standard buprenorphine formulation for pregnant patients with opioid use disorder. Treatment with buprenorphine during pregnancy is the clinical standard — untreated OUD carries far higher fetal risk than the medication.
Does Kentucky Medicaid cover Subutex?
Kentucky Medicaid plans typically cover Subutex, with most plans requiring documentation of the clinical indication (typically pregnancy) for prior authorization. Pregnancy-related authorizations are usually expedited.
Can I switch from Suboxone to Subutex?
Yes, when clinically appropriate. The switch is straightforward because the therapeutic component (buprenorphine) is identical. Most patients notice no clinical difference. The medication decision is made with the prescriber after the clinical assessment.
Is Subutex still made?
The brand-name Subutex was discontinued in the U.S., but generic buprenorphine monoproduct (the same medication) remains widely available and prescribed. Pharmacies and prescribers typically refer to it as 'buprenorphine' or 'buprenorphine monoproduct.'
Talk to admissions about Subutex.
Admissions answers 24/7. Golden Grove will accept Kentucky Medicaid. Coverage check happens on the call.